QMS compliance achieved

Agilent Technologies has released a statement reporting that its portfolio of DNA microarrays is now manufactured under ISO 13485 certification, a recognized standard for quality management systems (QMS).

Robert Schueren, Agilent vice president and general manager, Genomics and Life Science Reagents, commented, “Agilent has always emphasized quality in the manufacture of microarrays and we’re very pleased to be adding the validation of ISO 13485-registered QMS on top of our existing ISO 9001 standard.”

Additionally, the company is preparing to take the next step in pursuing clearance from the US FDA for a cytogenetics platform, according to vice president and general manager of the Biological Systems division, Gustavo Salem.

For more information on the company and its products visit the website at www.agilent.com

This story originally appeared in The Column. Click here to view that issue.